Conservative treatment using a methotrexate-lipiodol emulsion containing non-ionic contrast medium for a cervical ectopic pregnancy.
We present a case in which a viable cervical pregnancy was successfully treated with preservation of the uterus. A 26 year old female presented with a 6 week cervical pregnancy with acute moderate bleeding. On the day of admission the patient underwent embolization of the descending uterine artery to decrease the bleeding. The following day, 4 mEq potassium chloride and methotrexate (MTX)(1 mg/kg) dissolved in saline was injected into the amniotic cavity using transvaginal sonographic guidance. The fetal heart beat ceased; however, the urinary beta-human chorionic gonadotrophin (HCG) concentration increased and the gestational sac size also increased. After a second injection of an emulsion of MTX (1 mg/kg) dissolved in a non-ionic contrast medium, iopamidol and lipiodol, the betaHCG concentration in the urine began to decrease. After a third injection with the same emulsion, the cervical mass became necrotic. The betaHCG concentrations in the urine and serum were undetectable and the external cervix returned to normal 44 days after admission. No vaginal bleeding or significant side effects of MTX were observed throughout the treatment. An in-vitro dissolution test revealed that the dissolution rate of MTX was slower from MTX-lipiodol-iopamidol with sonication than without sonication. The present study indicates that use of an MTX emulsion enables slow release of MTX and may be applicable for conservative treatment of ectopic pregnancies, including cervical pregnancy.
Nomiyama
M
M
Department of Obstetrics and Gynecology, Saga Medical School, Nabeshima, Japan.
Arima
K
K
Iwasaka
T
T
Matsunaga
H
H
Kato
A
A
Sugimori
H
H
D000328:Adult; D002584:Cervix Uteri / Q000000981:diagnostic imaging / Q000473:pathology; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood / Q000652:urine; D003287:Contrast Media; D004655:Emulsions; D005260:Female; D006801:Humans; D007459:Iodized Oil; D007479:Iopamidol; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D009336:Necrosis; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D013010:Sonication; D014463:Ultrasonography
D018997:Chorionic Gonadotropin, beta Subunit, Human; D003287:Contrast Media; D004655:Emulsions; D007459:Iodized Oil; D007479:Iopamidol; D008727:Methotrexate